Article Details
Retrieved on: 2019-11-24 02:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>O : LEERINK RAISES TARGET PRICE TO $38 FROM $20; 08/03/2018 Mirati Therapeutics 4Q Loss/Shr 67c; 15/05/2018 – <b>Millennium Management</b> ...</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here